Panacea Global, Inc. (PGI) is a biotechnology company focusing on developing and commercializing products for the early detection, diagnosis and monitoring the recurrence of cancer. Panacea’s novel product is a blood test that can detect the presence of cancer in humans using a novel cancer biomarker named Human Aspartyl (Asparaginyl) B-Hydroxylase (HAAH), an enzyme which is over expressed in cancer cells and is the foundation of our breakthrough technology.
PANACEA GLOBAL, I (Other OTC: PANG) Jul 24, 3:59PM EDT
Last Price Change Open Day High 52-Week High
0.39
0.000 up(0.00%) 0.39 1.00
Volume Previous Close Day Low 52-Week Low
0 0.39 0.30

Bc DETECT

Bc Detect® is a novel blood test which aids the detection of recurrence of breast cancer. The test provides diagnostic information about breast cancer by measuring the level of HAAH in serum. Serum HAAH levels are significantly elevated in women with breast cancer compared to levels in cancer-free women. In addition, HAAH levels are elevated in the serum of women with stage I, II, III and IV breast but not in the serum of most patients in complete remission.

Cc DETECT

Cc Detect® is a serum test for colorectal cancer screening. It works by measuring serum levels of Human Aspartyl (Asparaginyl) ? -Hydroxylase (HAAH). HAAH levels are significantly elevated in people with colorectal cancer compared to levels in cancer-free individuals. HAAH levels are elevated in the serum of individuals with stage I, II, III and IV colorectal cancer but not in the serum of most who are not known to have cancer.

Lc DETECT

LC Detect® is a serum test for lung cancer screening. It works by measuring the serum levels of Human Aspartyl (Asparaginyl) -Hydroxylase (HAAH). LC Detect® is recommended for men and women, 50 years of age or older, who have smoked cigarettes extensively in the past, regardless of whether they currently smoke. HAAH levels in the serum of individuals with lung cancer are three-fold higher when compared to individuals who are cancer-free. LC Detect® provides useful information about the likelihood of lung cancer in those at highest risk for the disease, such as current or former smokers.

Pc DETECT

Pc Detect® was developed in order to improve the early accurate diagnosis of prostate cancer. It is a sensitive and specific test to complement current screening methods and to provide information about the probability of prostate cancer in men with PSA values < 4 ng/mL.Men with prostate cancer have higher serum HAAH levels than men without prostate cancer.

Latest News

May 29, 2014 (ACCESSWIRE via COMTEX) — Whitefish, MT / May 29, 2014 / Most…

TORONTO, ONTARIO, May 29, 2014 (Marketwired via COMTEX) — Panacea Global Inc. PANG -14.75% (…

TORONTO, ONTARIO, May 28, 2014 (Marketwired via COMTEX) — Panacea Global Inc. PANG -14.75% ,…